Breaking News

Thursday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Recommendations	Edison International price target lowered to $68 from $73 at UBS » 06:22 06/30/22 06/30 06:22 06/30/22 06:22 EIX Edison International $62.84 / +0.49 (+0.79%) UBS analyst Ross Fowler… UBS analyst Ross Fowler lowered the firm's price target on Edison International to $68 from $73 and keeps a Neutral rating on the shares as part of a broader research note on North American Power and Utilities. The analyst is shifting to a "less bullish" backdrop and a more "stock-picking environment" focused on lower risk fundamentals and valuation. In some of the prior cycles where the Fed increases rates by 300bp or more, utilities were relative underperformers by double-digit percentages, Fowler tells investors in a research note, stating that he is now changing his view from one where macro tail winds around the Fed raising rates and a recession thesis drove significant rotational fund flows to defense, to one where there are increasing risks of Fed rate hikes beyond 300bp. ShowHide Related Items >><< Street Research Earnings On The Fly Events EIX Edison International $62.84 / +0.49 (+0.79%) 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 05/10/22 Mizuho Edison International downgraded to Neutral from Buy at Mizuho 05/04/22 Citi Edison International price target raised to $79 from $67 at Citi EIX Edison International $62.84 / +0.49 (+0.79%) 05/03/22 Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04 EIX Edison International $62.84 / +0.49 (+0.79%) 06/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/28/22 Edison International - EIX

Over a week ago
Conference/Events	Edison International management to meet virtually with Seaport Global » 04:55 06/24/22 06/24 04:55 06/24/22 04:55 EIX Edison International $60.71 / +0.6 (+1.00%) Virtual Meeting to be… Virtual Meeting to be held on June 24 hosted by Seaport Global. ShowHide Related Items >><< Street Research Earnings On The Fly Events EIX Edison International $60.71 / +0.6 (+1.00%) 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 05/10/22 Mizuho Edison International downgraded to Neutral from Buy at Mizuho 05/04/22 Citi Edison International price target raised to $79 from $67 at Citi EIX Edison International $60.71 / +0.6 (+1.00%) 05/03/22 Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04 EIX Edison International $60.71 / +0.6 (+1.00%) 06/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/24/22 Edison International
Conference/Events	Edison International management to meet virtually with Seaport Global » 15:46 06/17/22 06/17 15:46 06/17/22 15:46 EIX Edison International $58.90 / -1.37 (-2.27%) Virtual Meeting to be… Virtual Meeting to be held on June 24 hosted by Seaport Global. ShowHide Related Items >><< Street Research Earnings On The Fly Events EIX Edison International $58.90 / -1.37 (-2.27%) 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 05/10/22 Mizuho Edison International downgraded to Neutral from Buy at Mizuho 05/04/22 Citi Edison International price target raised to $79 from $67 at Citi EIX Edison International $58.90 / -1.37 (-2.27%) 05/03/22 Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04 EIX Edison International $58.90 / -1.37 (-2.27%) 06/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/24/22 Edison International
On The Fly	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:59 06/06/22 06/06 09:59 06/06/22 09:59 SPOT Spotify $113.53 / +1.24 (+1.10%) , CRWD Crowdstrike $164.16 / +2.095 (+1.29%) , LULU Lululemon $302.50 / +1.6 (+0.53%) , DASH DoorDash $69.18 / +1.12 (+1.65%) , ACB Aurora Cannabis $1.61 / +0.01 (+0.63%) , AXP American Express $169.54 / +2.68 (+1.61%) , TPTX Turning Point Therapeutics $75.05 / +0.47 (+0.63%) , BMY Bristol-Myers $75.48 / +0.325 (+0.43%) , PMVP PMV Pharmaceuticals $13.96 / +0.12 (+0.87%) , SWTX SpringsWorks Therapeutics $21.51 / -0.11 (-0.51%) , RVMD Revolution Medicines $19.17 / +0.06 (+0.31%) , FSTR L.B. Foster $13.18 / + (+0.00%) , EIX Edison International $69.57 / -0.12 (-0.17%) , DNB Dun & Bradstreet $16.66 / +0.21 (+1.28%) , GDRX GoodRx $7.65 / +0.085 (+1.12%) , KR Kroger $52.87 / +0.335 (+0.64%) , BLCO Bausch + Lomb $16.74 / +0.13 (+0.78%) , SEMR Semrush $11.09 / +0.05 (+0.45%) , HNVR Hanover Bancorp $20.83 / +0.11 (+0.53%) , SLGBF Good Natured Products / + Institutional investors… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TPTX SWTX SPOT SEMR RVMD PMVP LULU KR GDRX FSTR EIX DNB DASH CRWD BMY BLCO AXP ACB TPTX Turning Point Therapeutics $75.05 / +0.47 (+0.63%) 06/03/22 Turning Point Therapeutics jumps 117% to $74.16 after Bristol-Myers buyout offer 06/03/22 Bristol-Myers to acquire Turning Point Therapeutics for $76.00 per share 06/03/22 Bristol-Myers to acquire Turning Point Therapeutics for $76.00 per share 05/16/22 Turning Point Therapeutics appoints Steve Sabus as CCO SWTX SpringsWorks Therapeutics $21.51 / -0.11 (-0.51%) 05/26/22 SpringsWorks Therapeutics presents Nirogacestat Clinical Data at 2022 ASCO 05/24/22 SpringsWorks Therapeutics: Nirogacestat achieved endpoints in Phase 3 DeFi trial 04/19/22 SpringsWorks announces agreeement with Regeneron for nirogacestat 12/10/21 SpringsWorks Therapeutics announces trial collaboration with AbbVie SPOT Spotify $113.53 / +1.24 (+1.10%) 05/04/22 Spotify introduces 'Spotify Island' on Roblox 04/27/22 Spotify falls -11.2% 04/27/22 Spotify falls -8.7% 04/27/22 Spotify: Guidance reflects full closure of services in Russia SEMR Semrush $11.09 / +0.05 (+0.45%) 02/28/22 Semrush plans acquisition of Austin-based Kompyte, no terms 01/19/22 Semrush acquires Backlinko.com, terms not disclosed RVMD Revolution Medicines $19.17 / +0.06 (+0.31%) 03/24/22 Revolution Medicines director buys $5.49M in common stock PMVP PMV Pharmaceuticals $13.96 / +0.12 (+0.87%) 05/26/22 PMV Pharmaceuticals: Lead program, PC14586 accepted as oral presentation at ASCO 04/27/22 PMV Pharmaceuticals to present initial PC14586 Phase 1 data at ASCO LULU Lululemon $302.50 / +1.6 (+0.53%) 06/02/22 Lululemon reports Q1 SSS up 28% or up 29% on constant FX 05/10/22 Nielsen selected by Lululemon as Marketing Mix Modeling provider 04/21/22 Xponential Fitness enters collaboration with Lululemon, MIRROR 04/20/22 Lululemon announces five year growth plan to double revenue to $12.5B by 2026 KR Kroger $52.87 / +0.335 (+0.64%) 06/06/22 Carl Icahn to discontinue proxy contest waged at Kroger, withdraw nominees 05/25/22 Kroger expands Fulfillment Network to Central Ohio 05/09/22 Else Nutrition receives formal listing approval for cereals on Kroger.com GDRX GoodRx $7.65 / +0.085 (+1.12%) 05/17/22 GoodRx announces strategic relationship with RxVantage 05/09/22 GoodRx 'unlikely' to achieve guidance provided on Q4 earnings call 05/09/22 GoodRx names former Uber grocery, new verticals chief Raj Beri as COO 05/02/22 GoodRx partners with AssistRx FSTR L.B. Foster $13.18 / + (+0.00%) 05/10/22 L.B. Foster sees funding operations in 2022 and beyond 03/01/22 L.B. Foster maintains 'optimistic outlook' regarding long-term trends EIX Edison International $69.57 / -0.12 (-0.17%) 12/09/21 Edison International raises quarterly dividend to 70c per share DNB Dun & Bradstreet $16.66 / +0.21 (+1.28%) 03/30/22 Dun & Bradstreet to divest business-to-consumer marketing business in Germany 02/16/22 Dun & Bradstreet announce 10-year strategic agreement 02/15/22 Cannae Holdings sells 20% interest in Optimal Blue to Black Knight for $578M 01/13/22 Dun & Bradstreet to make operational changes, refunds to settle FTC charges DASH DoorDash $69.18 / +1.12 (+1.65%) 05/20/22 DoorDash discloses $400M share repurchase program 05/16/22 Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe 05/12/22 Instacart announces confidential submission of draft registration statement CRWD Crowdstrike $164.16 / +2.095 (+1.29%) 05/16/22 Tiger Global buys Starry, exits Adobe in Q1 04/08/22 Crowdstrike targets over $5B in annual recurring revenue 04/07/22 Crowdstrike announces IL-4 authorization to protect DOD assets 04/07/22 Crowdstrike, Mandiant announce strategic partnership BMY Bristol-Myers $75.48 / +0.325 (+0.43%) 06/06/22 Bristol-Myers reports three-year data from Phase 3 CheckMate -9LA trial 06/06/22 Bristol-Myers reports five-year data from Phase 3 CheckMate -227 trial 06/03/22 Bristol-Myers withdraws sBLA for Reblozyl BLCO Bausch + Lomb $16.74 / +0.13 (+0.78%) 06/06/22 Bausch + Lomb announces seven presentations on Biotrue products 06/02/22 Bausch + Lomb announces U.S. launch of Biotrue Hydration Plus Solution 05/24/22 Bausch + Lomb receives Health Canada approval for Lumify 05/12/22 Bausch + Lomb release survey findings on macular edema treatment AXP American Express $169.54 / +2.68 (+1.61%) 05/16/22 Berkshire Hathaway adds Citi, exits Wells Fargo in Q1 05/10/22 American Express partners with Versapay for accounts receivable experience 04/28/22 American Express enters integration collaboration with Billtrust 04/13/22 Bread Financial launches new consumer credit card ACB Aurora Cannabis $1.61 / +0.01 (+0.63%) 06/03/22 Aurora Cannabis repurchases $20M of convertible senior notes 05/18/22 Aurora Cannabis receives EU-GMP certification for facility in Germany 05/12/22 Aurora Cannabis raises expense savings target to C$150M-C$170M 03/22/22 Aurora Cannabis to acquire Thrive Cannabis for $38M SPOT CRWD LULU DASH ACB AXP TPTX BMY PMVP SWTX RVMD FSTR EIX DNB GDRX KR BLCO SEMR HNVR SLGBF SPOT Spotify $113.53 / +1.24 (+1.10%) 06/06/22 Raymond James Raymond James upgrades Spotify to buy with bad news priced in 06/06/22 Raymond James Spotify upgraded to Outperform from Market Perform at Raymond James 04/29/22 Citi Spotify price target lowered to $165 from $240 at Citi 04/28/22 Truist Spotify price target lowered to $150 from $210 at Truist CRWD Crowdstrike $164.16 / +2.095 (+1.29%) 06/06/22 Morgan Stanley Crowdstrike upgraded to Overweight from Equal Weight at Morgan Stanley 06/03/22 Morgan Stanley Crowdstrike price target raised to $195 from $181 at Morgan Stanley 06/03/22 Jefferies Crowdstrike price target raised to $215 from $200 at Jefferies 06/03/22 DA Davidson Crowdstrike price target lowered to $235 from $280 at DA Davidson LULU Lululemon $302.50 / +1.6 (+0.53%) 06/06/22 Barclays Lululemon price target lowered to $435 from $450 at Barclays 06/06/22 Bernstein Lululemon upgraded to Market Perform from Underperform at Bernstein 06/03/22 UBS Lululemon price target lowered to $365 from $430 at UBS 06/03/22 Morgan Stanley Lululemon Q1 results 'speak for themselves,' says Morgan Stanley DASH DoorDash $69.18 / +1.12 (+1.65%) 06/06/22 Raymond James DoorDash initiated with a Market Perform at Raymond James 06/03/22 DA Davidson DoorDash price target lowered to $82 from $135 at DA Davidson 06/02/22 JMP Securities DoorDash price target lowered to $150 from $200 at JMP Securities 06/02/22 Truist DoorDash price target lowered to $185 from $200 at Truist ACB Aurora Cannabis $1.61 / +0.01 (+0.63%) 06/06/22 Stifel Aurora Cannabis upgraded to Hold from Sell at Stifel 05/16/22 CIBC Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC 05/13/22 Cantor Fitzgerald Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald 04/01/22 Alliance Global Partners Senate remains the hurdle for MORE Act, says Alliance Global Partners AXP American Express $169.54 / +2.68 (+1.61%) 06/06/22 Edward Jones American Express upgraded to Buy from Hold at Edward Jones 05/12/22 Wolfe Research Wolfe downgrades credit card issuers on 80% probability of recession 05/12/22 Wolfe Research American Express downgraded to Peer Perform from Outperform at Wolfe Research 04/26/22 Citi American Express price target raised to $190 from $187 at Citi TPTX Turning Point Therapeutics $75.05 / +0.47 (+0.63%) 06/06/22 Cowen Turning Point Therapeutics downgraded to Market Perform from Outperform at Cowen 06/06/22 H.C. Wainwright Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 06/05/22 BofA BofA keeps Buy on Bristol-Myers, raises price target to $80 06/03/22 Oppenheimer Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer BMY Bristol-Myers $75.48 / +0.325 (+0.43%) 06/03/22 Stifel Bristol-Myers' offer for Turning Point Therapeutics 'fair,' says Stifel PMVP PMV Pharmaceuticals $13.96 / +0.12 (+0.87%) 03/02/22 Oppenheimer Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target 03/02/22 Oppenheimer PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer 09/22/21 Goldman Sachs PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs SWTX SpringsWorks Therapeutics $21.51 / -0.11 (-0.51%) 06/06/22 H.C. Wainwright SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright 05/27/22 Wedbush SpringsWorks Therapeutics price target lowered to $50 from $110 at Wedbush 05/24/22 Goldman Sachs SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs RVMD Revolution Medicines $19.17 / +0.06 (+0.31%) 05/20/22 BofA BofA starts Revolution Medicines at Neutral with $24 price target 05/20/22 BofA Revolution Medicines initiated with a Neutral at BofA 03/01/22 Stifel Stifel upgrades Revolution Medicines, sees good entry point after pullback FSTR L.B. Foster $13.18 / + (+0.00%) 06/06/22 B. Riley L.B. Foster downgraded to Neutral on inflation headwinds at B. Riley 06/06/22 B. Riley L.B. Foster downgraded to Neutral from Buy at B. Riley 03/10/22 B. Riley L.B. Foster price target lowered to $18 from $21 at B. Riley 08/04/21 B. Riley L.B. Foster price target raised to $21 from $19 at B. Riley EIX Edison International $69.57 / -0.12 (-0.17%) 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 05/10/22 Mizuho Edison International downgraded to Neutral from Buy at Mizuho 05/04/22 Citi Edison International price target raised to $79 from $67 at Citi DNB Dun & Bradstreet $16.66 / +0.21 (+1.28%) 06/06/22 RBC Capital Dun & Bradstreet downgraded to Sector Perform from Outperform at RBC Capital 06/06/22 RBC Capital Dun & Bradstreet downgraded to Sector Perform from Outperform at RBC Capital 05/17/22 Barclays Dun & Bradstreet price target lowered to $18 from $22 at Barclays 05/10/22 Needham Dun & Bradstreet price target lowered to $21 from $28 at Needham GDRX GoodRx $7.65 / +0.085 (+1.12%) 06/06/22 BofA GoodRx reinstated with a Buy at BofA 06/01/22 Baird Baird downgrades GoodRx to Neutral amid disruption at Kroger 06/01/22 Baird GoodRx downgraded to Neutral from Outperform at Baird 05/16/22 Baird Baird 'hypothesizing' GoodRx PBM/pharmacy issue at Kroger may be improving KR Kroger $52.87 / +0.335 (+0.64%) 06/06/22 Guggenheim Kroger price target raised to $57 from $49 at Guggenheim 06/02/22 Deutsche Bank Kroger price target raised to $50 from $49 at Deutsche Bank BLCO Bausch + Lomb $16.74 / +0.13 (+0.78%) 06/06/22 Citi Bausch + Lomb initiated with a Buy at Citi 05/31/22 Jefferies Bausch + Lomb initiated with a Buy at Jefferies 05/31/22 BofA Bausch + Lomb initiated with a Buy at BofA 05/31/22 Deutsche Bank Bausch + Lomb initiated with a Hold at Deutsche Bank SEMR Semrush $11.09 / +0.05 (+0.45%) 06/06/22 Morgan Stanley Semrush initiated with an Equal Weight at Morgan Stanley 05/12/22 KeyBanc KeyBanc downgrades Semrush to Sector Weight on relocation, SMB risks/expenses 05/12/22 KeyBanc Semrush downgraded to Sector Weight from Overweight at KeyBanc 05/12/22 Jefferies Semrush price target lowered to $10 from $15 at Jefferies HNVR Hanover Bancorp $20.83 / +0.11 (+0.53%) 06/06/22 Stephens Hanover Bancorp initiated with an Overweight at Stephens 06/06/22 Piper Sandler Hanover Bancorp initiated with an Overweight at Piper Sandler SLGBF Good Natured Products / + 06/06/22 Raymond James Good Natured Products downgraded to Market Perform from Outperform at Raymond James 12/14/21 National Bank Good Natured Products initiated with an Outperform at National Bank 11/02/21 Raymond James Good Natured Products price target lowered to C$1.50 from C$2 at Raymond James 10/29/21 Canaccord Good Natured Products price target lowered to C$1.20 from C$1.90 at Canaccord TPTX SWTX SPOT SEMR RVMD PMVP LULU KR GDRX FSTR EIX DNB DASH CRWD BMY BLCO AXP ACB TPTX Turning Point Therapeutics $75.05 / +0.47 (+0.63%) 05/10/22 Turning Point Therapeutics reports Q1 EPS ($1.50), consensus ($1.51) 02/28/22 Turning Point Therapeutics reports Q4 EPS ($1.58), consensus ($1.39) SWTX SpringsWorks Therapeutics $21.51 / -0.11 (-0.51%) 05/05/22 SpringsWorks Therapeutics reports Q1 EPS ($1.26), consensus ($1.02) 02/24/22 SpringsWorks Therapeutics reports Q4 EPS ($1.15), consensus (88c) SPOT Spotify $113.53 / +1.24 (+1.10%) 04/27/22 Spotify sees Q2 revenue EUR 2.8B, MAUs 428M 04/27/22 Spotify reports Q1 EPS EUR 0.21 vs. (EUR 0.25) last year 02/02/22 Spotify reports Q4 EPS (EUR0.21) vs (EUR0.66) last year SEMR Semrush $11.09 / +0.05 (+0.45%) 05/10/22 Semrush sees FY22 revenue $249M-$251M, consensus $244.94M 05/10/22 Semrush sees Q2 revenue $59.5M-$60.5M, consensus $59.03M 05/10/22 Semrush reports Q1 EPS (2c), consensus (3c) 02/28/22 Semrush sees FY22 revenue $245M-$247M, consensus $237.4M RVMD Revolution Medicines $19.17 / +0.06 (+0.31%) 05/09/22 Revolution Medicines sees FY22 GAAP net loss $260M-$290M 05/09/22 Revolution Medicines reports Q1 EPS (78c), consensus (77c) 02/28/22 Revolution Medicines reports Q3 EPS (71c), consensus (64c) PMVP PMV Pharmaceuticals $13.96 / +0.12 (+0.87%) 05/10/22 PMV Pharmaceuticals reports Q1 EPS (41c), consensus (40c) 03/01/22 PMV Pharmaceuticals reports 2021 EPS ($1.28), consensus ($1.22) LULU Lululemon $302.50 / +1.6 (+0.53%) 06/02/22 Lululemon raises FY22 EPS view to $9.35-$9.50 from $9.15-$9.35, consensus $9.28 06/02/22 Lululemon sees Q2 EPS $1.89-$1.94, consensus $1.77 06/02/22 Lululemon reports Q1 EPS $1.48, consensus $1.43 KR Kroger $52.87 / +0.335 (+0.64%) 03/03/22 Kroger sees FY22 adjusted EPS $3.75-$3.85, consensus $3.45 03/03/22 Kroger reports Q4 adjusted EPS 91c, consensus 74c 03/02/22 Notable companies reporting before tomorrow's open GDRX GoodRx $7.65 / +0.085 (+1.12%) 05/09/22 GoodRx sees Q2 revenue about $190M, consensus $215.62M 05/09/22 GoodRx reports Q1 adjusted EPS 10c, consensus 8c 05/09/22 Notable companies reporting after market close 02/28/22 GoodRx sees FY22 revenue growth roughly 23%, consensus $1.02B FSTR L.B. Foster $13.18 / + (+0.00%) 05/10/22 L.B. Foster reports Q1 EPS (15c), consensus (2c) 03/01/22 L.B. Foster reports Q4 EPS (3c), two estimates 19c EIX Edison International $69.57 / -0.12 (-0.17%) 05/03/22 Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04 DNB Dun & Bradstreet $16.66 / +0.21 (+1.28%) 05/09/22 Dun & Bradstreet sees FY22 adjusted EPS $1.13-$1.20, consensus $1.15 05/09/22 Dun & Bradstreet reports Q1 adjusted EPS 24c, consensus 23c 02/16/22 Dun & Bradstreet reports Q4 EPS (3c) consensus 3c DASH DoorDash $69.18 / +1.12 (+1.65%) 05/05/22 DoorDash reports Q1 EPS (48c), consensus (41c) 05/05/22 Notable companies reporting after market close 02/16/22 DoorDash reports Q4 EPS (45c), consensus (25c) 02/16/22 Notable companies reporting after market close CRWD Crowdstrike $164.16 / +2.095 (+1.29%) 06/02/22 CrowdStrike raises FY23 EPS view to $1.18-$1.22 from $1.03-$1.13 06/02/22 CrowdStrike sees Q2 adjusted EPS 27c-28c, consensus 24c 06/02/22 CrowdStrike reports Q1 adjusted EPS 31c, consensus 23c 06/02/22 Notable companies reporting after market close BMY Bristol-Myers $75.48 / +0.325 (+0.43%) 04/29/22 Bristol-Myers lowers FY22 adjusted EPS view to $7.44-$7.74 from $7.65-$7.95 04/29/22 Bristol-Myers reports Q1 EPS $1.96, consensus $1.91 04/28/22 Notable companies reporting before tomorrow's open BLCO Bausch + Lomb $16.74 / +0.13 (+0.78%) 05/10/22 Bausch Health sees 2022 revenue $8.25B-$8.4B, consensus $8.57B AXP American Express $169.54 / +2.68 (+1.61%) 04/22/22 American Express reports Q1 EPS $2.73, consensus $2.44 02/27/22 Berkshire operating earnings surge, Buffett repurchases record $27B in stock 01/25/22 American Express sees FY22 EPS $9.25-$9.65, consensus $9.67 01/25/22 American Express reports Q4 EPS $2.18, consensus $1.87 ACB Aurora Cannabis $1.61 / +0.01 (+0.63%) 05/12/22 Aurora Cannabis reports Q3 revenue C$50.43M vs. C$55.16M a year ago 02/10/22 Aurora Cannabis reports Q2 adjusted EBITDA (C$9M) vs. (C$11.5) in Q1 02/10/22 Aurora Cannabis reports Q2 revenue C$60.6M, vs. C$67.67M a year ago 01/04/22 Aurora Cannabis to deliver C$10M cannabis shipment to Israel 27 May 11 May 06 May 19 Nov 19 Aug 28 Jun SPOT PMVP LULU KR DASH CRWD BMY BLCO AXP ACB SPOT Spotify $113.53 / +1.24 (+1.10%) 05/16/22 Spotify tells TechCrunch it is testing feature to let artists promote NFTs 05/12/22 Spotify promotes Bill Simmons to oversee global sports strategy, Verge reports 05/06/22 Spotify Stations app shutting down later this month, 9to5Google reports 04/30/22 Spotify falling short in ways that bode poorly for stock, Barron's says PMVP PMV Pharmaceuticals $13.96 / +0.12 (+0.87%) 05/19/22 Wolfpack issues short report on 'significantly overpriced' PMV 05/19/22 Wolfpack Research announces short position in PMV Pharmaceuticals LULU Lululemon $302.50 / +1.6 (+0.53%) 01/05/22 Lululemon tells CNBC Nike patents in question 'overly broad and invalid' 01/05/22 Nike lawsuit claims Lululemon infringed patents with Mirror device, CNBC says KR Kroger $52.87 / +0.335 (+0.64%) 06/05/22 Icahn drops proxy fight over pig treatment at Kroger, WSJ reports 03/19/22 Brinker, Starbucks among stocks to buy among rising food costs, Barron's says 01/12/22 Over 8,000 King Soopers workers go on strike as negotiations stall, Reuters says 01/06/22 Consumer Reports says harmful bacteria found in Kroger-brand ground beef test DASH DoorDash $69.18 / +1.12 (+1.65%) 05/12/22 Instacart listing could happen as soon as this year, Bloomberg reports 03/23/22 Instacart plans to launch 15-minute grocery delivery service, Information says 03/17/22 Ride-hailing, delivery app drivers stretched amid spiking gas prices, NYT says 03/08/22 Uber, Lyft, others launch ad campaign to prevent unions, WSJ reports CRWD Crowdstrike $164.16 / +2.095 (+1.29%) 05/21/22 Some stocks that aren't as cheap as they look, Barron's says BMY Bristol-Myers $75.48 / +0.325 (+0.43%) 05/28/22 Buy Bristol-Myers, rally just getting started, Barron's says BLCO Bausch + Lomb $16.74 / +0.13 (+0.78%) 05/05/22 Bausch + Lomb seen pricing IPO at low end of expectations, WSJ says AXP American Express $169.54 / +2.68 (+1.61%) 04/16/22 American Express investigated by IRS over tax break sales pitch, WSJ says 03/31/22 Amazon decides to renew Prime credit card tie-up with JPMorgan, CNBC reports 03/06/22 American Express suspends operations in Russia, Belarus, Bloomberg reports ACB Aurora Cannabis $1.61 / +0.01 (+0.63%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says TPTX SWTX SPOT RVMD PMVP LULU KR GDRX DASH CRWD BMY BLCO AXP ACB TPTX Turning Point Therapeutics $75.05 / +0.47 (+0.63%) 05/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SWTX SpringsWorks Therapeutics $21.51 / -0.11 (-0.51%) 05/24/22 What You Missed On Wall Street On Tuesday 05/24/22 What You Missed On Wall Street This Morning 05/13/22 Proven algorithm says sell these stocks now SPOT Spotify $113.53 / +1.24 (+1.10%) 04/28/22 What You Missed On Wall Street On Thursday 04/28/22 What You Missed On Wall Street This Morning 04/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/27/22 What You Missed On Wall Street On Wednesday RVMD Revolution Medicines $19.17 / +0.06 (+0.31%) 03/28/22 Fly Insider: GameStop, Agilent among this week's notable insider trades 03/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PMVP PMV Pharmaceuticals $13.96 / +0.12 (+0.87%) 05/27/22 What You Missed On Wall Street On Friday 05/27/22 What You Missed On Wall Street This Morning 05/26/22 Fly Intel: After-Hours Movers LULU Lululemon $302.50 / +1.6 (+0.53%) 06/02/22 Fly Intel: After-Hours Movers KR Kroger $52.87 / +0.335 (+0.64%) 04/08/22 What You Missed On Wall Street On Friday 04/08/22 What You Missed On Wall Street This Morning 04/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/04/22 What You Missed On Wall Street On Friday GDRX GoodRx $7.65 / +0.085 (+1.12%) 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 06/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/10/22 What You Missed On Wall Street On Tuesday DASH DoorDash $69.18 / +1.12 (+1.65%) 06/04/22 Opening Day: Zhong Yang rises 240% in market debut 05/20/22 Fly Intel: Pre-market Movers 05/14/22 Opening Day: Fracking company ProFrac comes public in downsized IPO 05/05/22 Fly Intel: After-Hours Movers CRWD Crowdstrike $164.16 / +2.095 (+1.29%) 06/06/22 Fly Intel: Pre-market Movers 06/03/22 What You Missed On Wall Street On Friday 06/03/22 What You Missed On Wall Street This Morning 06/03/22 Fly Intel: Pre-market Movers BMY Bristol-Myers $75.48 / +0.325 (+0.43%) 05/12/22 Fly Intel: Pre-market Movers BLCO Bausch + Lomb $16.74 / +0.13 (+0.78%) 05/31/22 What You Missed On Wall Street On Tuesday 05/31/22 What You Missed On Wall Street This Morning 05/31/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations AXP American Express $169.54 / +2.68 (+1.61%) 05/12/22 What You Missed On Wall Street On Thursday 05/12/22 What You Missed On Wall Street This Morning 05/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/22/22 What You Missed On Wall Street On Friday ACB Aurora Cannabis $1.61 / +0.01 (+0.63%) 06/02/22 Here's What You Missed in Cannabis This Week 05/26/22 Rising High: Exclusive talk with cannabis company Tyson 2.0 05/19/22 Rising High: Exclusive talk with biotech company Tryp Therapeutics 05/12/22 Rising High: Exclusive talk with cannabis REIT NewLake Capital 06/06/22 FinTech Virtual Bus Tour 06/08/22 5th Annual Cross Sector Insight Conference 06/08/22 Oppenheimer Hosted Company Meetings at RSA Conference 06/08/22 Money 20/20 Europe 06/09/22 EHA 2022 09/19/22 Groceryshop 06/08/22 Bausch + Lomb - BLCO 06/16/22 Kroger - KR 07/27/22 Bristol-Myers - BMY 09/10/22 PDUFA Date for Deucravacitinib (POETYK PSO-2) 06/08/22 Lululemon Athletica Inc. 06/14/22 GoodRx Holdings Inc. 06/15/22 Semrush 06/16/22 Revolution Medicines, Inc. 06/16/22 Dun & Bradstreet Holdings, Inc. 06/16/22 Turning Point Therapeutics, Inc. 06/23/22 Kroger Co. 06/23/22 DoorDash, Inc. 06/24/22 Edison International 06/29/22 CrowdStrike Holdings, Inc. SPOT SEMR LULU KR GDRX DASH CRWD BMY BLCO AXP ACB SPOT Spotify $113.53 / +1.24 (+1.10%) 04/21/22 Spotify put volume heavy and directionally bearish 02/10/22 Spotify call buyer realizes 37% same-day gains 02/02/22 Spotify options imply 11.1% move in share price post-earnings 01/31/22 Unusually active option classes on open January 31st SEMR Semrush $11.09 / +0.05 (+0.45%) 12/31/21 Sixteen new option listings and one option delisting on December 31st LULU Lululemon $302.50 / +1.6 (+0.53%) 06/02/22 Lululemon options imply 7.9% move in share price post-earnings 03/29/22 Lululemon options imply 7.1% move in share price post-earnings 02/03/22 Lululemon put volume heavy and directionally bearish 01/10/22 Unusually active option classes on open January 10th KR Kroger $52.87 / +0.335 (+0.64%) 05/25/22 Unusually active option classes on open May 25th 05/19/22 Unusually active option classes on open May 19th 05/18/22 Kroger put volume heavy and directionally bearish 04/25/22 Unusual call flow in option market yesterday GDRX GoodRx $7.65 / +0.085 (+1.12%) 05/09/22 GoodRx Holdings options imply 17.9% move in share price post-earnings DASH DoorDash $69.18 / +1.12 (+1.65%) 06/01/22 DoorDash put volume heavy and directionally bearish 05/05/22 DoorDash options imply 13.1% move in share price post-earnings 05/05/22 Unusually active option classes on open May 5th 04/26/22 DoorDash put volume heavy and directionally bearish CRWD Crowdstrike $164.16 / +2.095 (+1.29%) 06/02/22 CrowdStrike Holdings options imply 8.0% move in share price post-earnings 06/02/22 Unusually active option classes on open June 2nd 05/20/22 Unusually active option classes on open May 20th 04/08/22 Unusually active option classes on open April 8th BMY Bristol-Myers $75.48 / +0.325 (+0.43%) 02/16/22 Bristol Myers Squibb call volume above normal and directionally bullish 01/10/22 Early notable gainers among liquid option names on January 10th 12/15/21 Bristol Myers Squibb call volume above normal and directionally bullish BLCO Bausch + Lomb $16.74 / +0.13 (+0.78%) 05/25/22 new option listings and one option delisting on May 25th AXP American Express $169.54 / +2.68 (+1.61%) 05/09/22 American Express call volume above normal and directionally bullish 04/25/22 American Express put volume heavy and directionally bearish 04/22/22 Unusually active option classes on open April 22nd 03/17/22 Early notable gainers among liquid option names on March 17th ACB Aurora Cannabis $1.61 / +0.01 (+0.63%) 05/31/22 Unusually active option classes on open May 31st 05/12/22 Aurora Cannabis options imply 13.6% move in share price post-earnings 05/10/22 Unusually active option classes on open May 10th 03/28/22 Unusually active option classes on open March 28th
Downgrade	Edison International downgraded to Neutral from Buy at UBS » 05:23 06/06/22 06/06 05:23 06/06/22 05:23 EIX Edison International $69.69 / -0.64 (-0.91%) UBS analyst Gregg Orrill… UBS analyst Gregg Orrill downgraded Edison International to Neutral from Buy with a price target of $73, down from $75. The analyst sees the investment positives and negatives as more balanced with the stock nearing the price target. Edison shares have risen 25% over the last 12 months and 4% over the last three months, Orrill points out. ShowHide Related Items >><< Company News Street Research Earnings Events EIX Edison International $69.69 / -0.64 (-0.91%) 12/09/21 Edison International raises quarterly dividend to 70c per share EIX Edison International $69.69 / -0.64 (-0.91%) 06/06/22 UBS Edison International downgraded to Neutral from Buy at UBS 05/10/22 Mizuho Edison International downgraded to Neutral from Buy at Mizuho 05/04/22 Citi Edison International price target raised to $79 from $67 at Citi 04/14/22 RBC Capital Edison International price target raised to $82 from $73 at RBC Capital EIX Edison International $69.69 / -0.64 (-0.91%) 05/03/22 Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04 06/24/22 Edison International
Downgrade	Edison International downgraded to Neutral from Buy at UBS » 05:21 06/06/22 06/06 05:21 06/06/22 05:21 EIX Edison International $69.69 / -0.64 (-0.91%) UBS analyst Gregg Orrill… UBS analyst Gregg Orrill downgraded Edison International to Neutral from Buy with a price target of $73, down from $75. ShowHide Related Items >><< Company News Street Research Earnings Events EIX Edison International $69.69 / -0.64 (-0.91%) 12/09/21 Edison International raises quarterly dividend to 70c per share EIX Edison International $69.69 / -0.64 (-0.91%) 05/10/22 Mizuho Edison International downgraded to Neutral from Buy at Mizuho 05/04/22 Citi Edison International price target raised to $79 from $67 at Citi 04/14/22 RBC Capital Edison International price target raised to $82 from $73 at RBC Capital 03/30/22 Wells Fargo Edison International price target raised to $79 from $70 at Wells Fargo EIX Edison International $69.69 / -0.64 (-0.91%) 05/03/22 Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04 06/24/22 Edison International

Over a month ago
Downgrade	Edison International downgraded to Neutral from Buy at Mizuho » 05:25 05/10/22 05/10 05:25 05/10/22 05:25 EIX Edison International $70.05 / -0.245 (-0.35%) Mizuho analyst Paul… Mizuho analyst Paul Fremont downgraded Edison International to Neutral from Buy with a price target of $72, down from $82. The analyst has concerns about the impact of rising interest rates on the earnings of the company's utility subsidiary Southern California Edison. He estimates that SCE will have roughly $6B of interest-exposed disallowed debt, which is not recoverable in rates. Every 1% increase in interest rates would reduce Edison's earnings per share by 11c, Fremont tells investors in a research note. ShowHide Related Items >><< Company News Street Research Earnings EIX Edison International $70.05 / -0.245 (-0.35%) 12/09/21 Edison International raises quarterly dividend to 70c per share EIX Edison International $70.05 / -0.245 (-0.35%) 05/04/22 Citi Edison International price target raised to $79 from $67 at Citi 04/14/22 RBC Capital Edison International price target raised to $82 from $73 at RBC Capital 03/30/22 Wells Fargo Edison International price target raised to $79 from $70 at Wells Fargo 01/31/22 Mizuho Edison International price target raised to $82 from $77 at Mizuho EIX Edison International $70.05 / -0.245 (-0.35%) 05/03/22 Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04
Recommendations	Edison International price target raised to $79 from $67 at Citi » 06:34 05/04/22 05/04 06:34 05/04/22 06:34 EIX Edison International $68.45 / +0.57 (+0.84%) Citi analyst Ryan Levine… Citi analyst Ryan Levine raised the firm's price target on Edison International to $79 from $67 and keeps a Buy rating on the shares. There is an end in sight for the company's wildfire liability, Levine tells investors in a research note. ShowHide Related Items >><< Company News Street Research Earnings EIX Edison International $68.45 / +0.57 (+0.84%) 12/09/21 Edison International raises quarterly dividend to 70c per share EIX Edison International $68.45 / +0.57 (+0.84%) 04/14/22 RBC Capital Edison International price target raised to $82 from $73 at RBC Capital 03/30/22 Wells Fargo Edison International price target raised to $79 from $70 at Wells Fargo 01/31/22 Mizuho Edison International price target raised to $82 from $77 at Mizuho 12/29/21 Argus Edison International price target raised to $73 from $68 at Argus EIX Edison International $68.45 / +0.57 (+0.84%) 05/03/22 Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04
Earnings	Edison International backs FY22 EPS view of $4.40-$4.70, consensus $4.51 16:42 05/03/22 05/03 16:42 05/03/22 16:42 EIX Edison International $68.45 / +0.57 (+0.84%) ShowHide Related Items >><< Company News Street Research Earnings Events EIX Edison International $68.45 / +0.57 (+0.84%) 12/09/21 Edison International raises quarterly dividend to 70c per share EIX Edison International $68.45 / +0.57 (+0.84%) 04/14/22 RBC Capital Edison International price target raised to $82 from $73 at RBC Capital 03/30/22 Wells Fargo Edison International price target raised to $79 from $70 at Wells Fargo 01/31/22 Mizuho Edison International price target raised to $82 from $77 at Mizuho 12/29/21 Argus Edison International price target raised to $73 from $68 at Argus EIX Edison International $68.45 / +0.57 (+0.84%) 05/03/22 Edison International reports Q1 EPS $1.07, consensus 79c 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04 05/03/22 Edison International - EIX
Earnings	Edison International reports Q1 EPS $1.07, consensus 79c » 16:41 05/03/22 05/03 16:41 05/03/22 16:41 EIX Edison International $68.45 / +0.57 (+0.84%) Reports Q1 revenue… Reports Q1 revenue $3.97B, consensus $3.29B. "SCE continues to make solid progress in substantially improving its wildfire risk profile," said Pedro J. Pizarro, CEO. "The cornerstone of SCE's grid hardening measures is the wildfire covered conductor program. Over the past year the utility nearly doubled its miles of installed covered conductor. SCE will continue to drive this valuable program forward and by year-end expects 40% of its overhead distribution lines in high fire risk areas will be covered. We strongly believe Edison International is the best investment vehicle to participate in California's clean energy transition. SCE's approach to wildfire mitigation has shown positive results over the last three wildfire seasons and the utility is expeditiously hardening the grid every day, to the benefit of both customers and investors. As an electric-only, wires-focused utility, SCE's ongoing investment in the grid will enable an electric-led future." ShowHide Related Items >><< Company News Street Research Earnings Events EIX Edison International $68.45 / +0.57 (+0.84%) 12/09/21 Edison International raises quarterly dividend to 70c per share EIX Edison International $68.45 / +0.57 (+0.84%) 04/14/22 RBC Capital Edison International price target raised to $82 from $73 at RBC Capital 03/30/22 Wells Fargo Edison International price target raised to $79 from $70 at Wells Fargo 01/31/22 Mizuho Edison International price target raised to $82 from $77 at Mizuho 12/29/21 Argus Edison International price target raised to $73 from $68 at Argus EIX Edison International $68.45 / +0.57 (+0.84%) 02/24/22 Edison International sees FY22 core EPS $4.40-$4.70, consensus $4.56 02/24/22 Edison International reports Q4 core EPS $1.16, consensus $1.04 05/03/22 Edison International - EIX

On The Fly

News and insights, exclusive to thefly.com

08:55	Fly Intel: Pre-market Movers»
18:18	Fly Intel: After-Hours Movers»
16:07	What You Missed On Wall Street On Tuesday»
12:09	What You Missed On Wall Street This Morning»
10:20	What You Missed This Week in EVs and Clean Energy»

View all On The Fly Stories »

Upcoming
Events (10)

	17th International Congress on Neuromuscular Diseases
	Annual Meeting 2022 of the BRS
TMO ...	16th World Immune Regulation Meeting 2022
	Asia Discovery Conference
	Solar Energy 20 Future Europe 2022
	3rd Annual Japan New Economy Day
GS ...	Berlin Disruptive Tech Symposium
BOX	Box
BIVI	BioVie
LCTX	Lineage Cell Therapeutics

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial